Divi's Laboratories Limited (DIVISLAB.BO)
INR 5849.2
(0.02%)
INR 5849.2
(0.02%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 31.84 Billion INR | 6.12% |
| 2022 | 30 Billion INR | 6.07% |
| 2021 | 28.28 Billion INR | 31.86% |
| 2020 | 21.45 Billion INR | 15.1% |
| 2019 | 18.63 Billion INR | 5.16% |
| 2018 | 17.72 Billion INR | 31.22% |
| 2017 | 13.5 Billion INR | 2.33% |
| 2016 | 13.19 Billion INR | 9.28% |
| 2015 | 12.07 Billion INR | 3.89% |
| 2014 | 11.62 Billion INR | 24.69% |
| 2013 | 9.32 Billion INR | 11.57% |
| 2012 | 8.35 Billion INR | 23.08% |
| 2011 | 6.78 Billion INR | 18.76% |
| 2010 | 5.71 Billion INR | 14.68% |
| 2009 | 4.98 Billion INR | 18.33% |
| 2008 | 4.21 Billion INR | 49.7% |
| 2007 | 2.81 Billion INR | 31.8% |
| 2006 | 2.13 Billion INR | 16.13% |
| 2005 | 1.83 Billion INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q4 | 31.84 Billion INR | 0.0% |
| 2023 FY | 31.84 Billion INR | 6.12% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 29.69 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 30 Billion INR | 0.0% |
| 2022 FY | 30 Billion INR | 6.07% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q2 | 29.69 Billion INR | 0.0% |
| 2021 FY | 28.28 Billion INR | 31.86% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q2 | 26.76 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 28.28 Billion INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 FY | 21.45 Billion INR | 15.1% |
| 2020 Q4 | 21.45 Billion INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q2 | 16.99 Billion INR | 0.0% |
| 2019 FY | 18.63 Billion INR | 5.16% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q4 | 18.63 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q2 | 19.09 Billion INR | 0.0% |
| 2018 FY | 17.72 Billion INR | 31.22% |
| 2018 Q4 | 17.72 Billion INR | 0.0% |
| 2018 Q1 | - INR | 0.0% |
| 2017 FY | 13.5 Billion INR | 2.33% |
| 2016 FY | 13.19 Billion INR | 9.28% |
| 2015 FY | 12.07 Billion INR | 3.89% |
| 2014 Q4 | 11.62 Billion INR | 0.0% |
| 2014 FY | 11.62 Billion INR | 24.69% |
| 2013 Q4 | 9.32 Billion INR | 0.0% |
| 2013 FY | 9.32 Billion INR | 11.57% |
| 2012 FY | 8.35 Billion INR | 23.08% |
| 2012 Q4 | 8.35 Billion INR | 0.0% |
| 2011 FY | 6.78 Billion INR | 18.76% |
| 2010 FY | 5.71 Billion INR | 14.68% |
| 2009 FY | 4.98 Billion INR | 18.33% |
| 2008 FY | 4.21 Billion INR | 49.7% |
| 2007 FY | 2.81 Billion INR | 31.8% |
| 2006 FY | 2.13 Billion INR | 16.13% |
| 2005 FY | 1.83 Billion INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Ajanta Pharma Limited | 8.28 Billion INR | -284.374% |
| Amrutanjan Health Care Limited | 289.04 Million INR | -10915.51% |
| Sigachi Industries Limited | 707.2 Million INR | -4402.218% |
| Bal Pharma Limited | 878.11 Million INR | -3525.953% |
| Ind-Swift Laboratories Limited | 104.57 Million INR | -30346.465% |
| Medico Remedies Limited | 163.37 Million INR | -19389.264% |
| Lasa Supergenerics Limited | 190.43 Million INR | -16619.703% |
| Venus Remedies Limited | 1.21 Billion INR | -2516.485% |
| Sun Pharma Advanced Research Company Limited | - INR | -Infinity% |
| Alpa Laboratories Limited | 136.65 Million INR | -23199.891% |
| Nectar Lifesciences Limited | 7.09 Billion INR | -348.987% |
| Shilpa Medicare Limited | 3.44 Billion INR | -823.091% |
| Aarti Drugs Limited | 4.85 Billion INR | -555.292% |
| Lupin Limited | 49.53 Billion INR | 35.727% |
| Aurobindo Pharma Limited | 98.08 Billion INR | 67.537% |
| Zydus Lifesciences Limited | 34.41 Billion INR | 7.493% |
| Windlas Biotech Limited | 621.89 Million INR | -5019.877% |
| Suven Life Sciences Limited | 7.08 Million INR | -449300.141% |
| Eris Lifesciences Limited | 1.89 Billion INR | -1584.371% |
| Valiant Laboratories Limited | 100.15 Million INR | -31691.042% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | -533.619% |
| Solara Active Pharma Sciences Limited | 3.59 Billion INR | -785.182% |
| Ipca Laboratories Limited | 24.71 Billion INR | -28.839% |
| Bliss GVS Pharma Limited | 1.18 Billion INR | -2588.115% |
| Achyut Healthcare Limited | 568 Thousand INR | -5605533.803% |
| Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 67.735% |
| Bajaj HealthCare Limited | 1.44 Billion INR | -2110.525% |
| RPG Life Sciences Limited | 1.01 Billion INR | -3052.475% |
| Mankind Pharma Limited | 15.53 Billion INR | -104.962% |
| Laurus Labs Limited | 18.45 Billion INR | -72.536% |
| Piramal Pharma Limited | 21.75 Billion INR | -46.332% |
| Syncom Formulations (India) Limited | 210.81 Million INR | -15003.29% |
| Torrent Pharmaceuticals Limited | 22.79 Billion INR | -39.71% |
| Alembic Pharmaceuticals Limited | 16.43 Billion INR | -93.728% |
| Glenmark Pharmaceuticals Limited | 25.13 Billion INR | -26.699% |
| Unichem Laboratories Limited | 7.04 Billion INR | -351.839% |
| Sequent Scientific Limited | 3.46 Billion INR | -819.615% |
| Novartis India Limited | 448.6 Million INR | -6997.637% |
| Wanbury Limited | 360.23 Million INR | -8738.748% |
| Suven Pharmaceuticals Limited | 2.31 Billion INR | -1277.188% |
| Wockhardt Limited | 6.4 Billion INR | -397.5% |
| Themis Medicare Limited | 705.74 Million INR | -4411.557% |
| Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -21130.913% |
| Jubilant Pharmova Limited | 12.89 Billion INR | -146.898% |
| Glenmark Life Sciences Limited | 6.66 Billion INR | -377.654% |
| Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 49.899% |
| NATCO Pharma Limited | 7 Billion INR | -354.532% |
| Gufic Biosciences Limited | 2 Billion INR | -1488.172% |
| IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | -649.459% |
| Ind-Swift Limited | 640.91 Million INR | -4867.897% |
| Procter & Gamble Health Limited | 1.09 Billion INR | -2818.156% |
| FDC Limited | 3.88 Billion INR | -718.743% |
| Krebs Biochemicals & Industries Limited | 97.96 Million INR | -32401.735% |
| Granules India Limited | 13 Billion INR | -144.82% |
| Medicamen Biotech Limited | 593.75 Million INR | -5262.508% |
| Alkem Laboratories Limited | 26.61 Billion INR | -19.646% |
| AstraZeneca Pharma India Limited | 2.27 Billion INR | -1297.214% |
| Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -124777.437% |
| Brooks Laboratories Limited | 96.1 Million INR | -33029.396% |
| Megasoft Limited | - INR | -Infinity% |
| ZIM Laboratories Limited | 812.62 Million INR | -3818.147% |
| Strides Pharma Science Limited | 11.26 Billion INR | -182.711% |
| Neuland Laboratories Limited | 3.5 Billion INR | -808.619% |
| Morepen Laboratories Limited | 2.48 Billion INR | -1180.802% |
| Hikal Limited | 3.03 Billion INR | -948.334% |
| Indoco Remedies Limited | 3.53 Billion INR | -801.83% |
| Aarti Pharmalabs Limited | 6.42 Billion INR | -395.287% |
| Kilitch Drugs (India) Limited | 39.88 Million INR | -79739.519% |
| Mangalam Drugs & Organics Limited | 1.23 Billion INR | -2475.223% |
| Hester Biosciences Limited | 755.81 Million INR | -4112.699% |